Literature DB >> 26661206

Direct voxel-based comparisons between grey matter shrinkage and glucose hypometabolism in chronic alcoholism.

Ludivine Ritz1, Shailendra Segobin1, Coralie Lannuzel1, Céline Boudehent2, François Vabret2, Francis Eustache1, Hélène Beaunieux1, Anne L Pitel3.   

Abstract

Alcoholism is associated with widespread brain structural abnormalities affecting mainly the frontocerebellar and the Papez's circuits. Brain glucose metabolism has received limited attention, and few studies used regions of interest approach and showed reduced global brain metabolism predominantly in the frontal and parietal lobes. Even though these studies have examined the relationship between grey matter shrinkage and hypometabolism, none has performed a direct voxel-by-voxel comparison between the degrees of structural and metabolic abnormalities. Seventeen alcoholic patients and 16 control subjects underwent both structural magnetic resonance imaging and (18)F-2-fluoro-deoxy-glucose-positron emission tomography examinations. Structural abnormalities and hypometabolism were examined in alcoholic patients compared with control subjects using two-sample t-tests. Then, these two patterns of brain damage were directly compared with a paired t-test. Compared to controls, alcoholic patients had grey matter shrinkage and hypometabolism in the fronto-cerebellar circuit and several nodes of Papez's circuit. The direct comparison revealed greater shrinkage than hypometabolism in the cerebellum, cingulate cortex, thalamus and hippocampus and parahippocampal gyrus. Conversely, hypometabolism was more severe than shrinkage in the dorsolateral, premotor and parietal cortices. The distinct profiles of abnormalities found within the Papez's circuit, the fronto-cerebellar circuit and the parietal gyrus in chronic alcoholism suggest the involvement of different pathological mechanisms.
© The Author(s) 2015.

Entities:  

Keywords:  Alcoholism; FDG–PET; Papez; fronto-cerebellar circuit; structural MRI

Mesh:

Substances:

Year:  2015        PMID: 26661206      PMCID: PMC5012518          DOI: 10.1177/0271678X15611136

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  Anatomical and functional alterations in semantic dementia: a voxel-based MRI and PET study.

Authors:  Béatrice Desgranges; Vanessa Matuszewski; Pascale Piolino; Gaël Chételat; Florence Mézenge; Brigitte Landeau; Vincent de la Sayette; Serge Belliard; Francis Eustache
Journal:  Neurobiol Aging       Date:  2006-09-15       Impact factor: 4.673

2.  Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning.

Authors:  Sandra Chanraud; Catherine Martelli; Francoise Delain; Nikoletta Kostogianni; Gwenaelle Douaud; Henri-Jean Aubin; Michel Reynaud; Jean-Luc Martinot
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

3.  In vivo mammillary body volume deficits in amnesic and nonamnesic alcoholics.

Authors:  E V Sullivan; B Lane; A Deshmukh; M J Rosenbloom; J E Desmond; K O Lim; A Pfefferbaum
Journal:  Alcohol Clin Exp Res       Date:  1999-10       Impact factor: 3.455

4.  Walk on floor eyes closed (WOFEC): a new addition to an ataxia test battery.

Authors:  A R Fregly; A Graybiel; M J Smith
Journal:  Aerosp Med       Date:  1972-04

5.  Estimating smoothness in statistical parametric maps: variability of p values.

Authors:  J B Poline; K J Worsley; A P Holmes; R S Frackowiak; K J Friston
Journal:  J Comput Assist Tomogr       Date:  1995 Sep-Oct       Impact factor: 1.826

Review 6.  The neuropathology of alcohol-related brain damage.

Authors:  Clive Harper
Journal:  Alcohol Alcohol       Date:  2009-01-15       Impact factor: 2.826

7.  Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

Authors:  Renaud La Joie; Audrey Perrotin; Louisa Barré; Caroline Hommet; Florence Mézenge; Méziane Ibazizene; Vincent Camus; Ahmed Abbas; Brigitte Landeau; Denis Guilloteau; Vincent de La Sayette; Francis Eustache; Béatrice Desgranges; Gaël Chételat
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  White matter damage is associated with memory decline in chronic alcoholics: a quantitative diffusion tensor tractography study.

Authors:  Richa Trivedi; Deepika Bagga; Debajyoti Bhattacharya; Prabhjot Kaur; Pawan Kumar; Subash Khushu; Rajendra Prashad Tripathi; Namita Singh
Journal:  Behav Brain Res       Date:  2013-05-10       Impact factor: 3.332

10.  Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics.

Authors:  E V Sullivan; L Marsh; D H Mathalon; K O Lim; A Pfefferbaum
Journal:  Alcohol Clin Exp Res       Date:  1995-02       Impact factor: 3.455

View more
  13 in total

Review 1.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

2.  Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment.

Authors:  Virgile Clergue-Duval; Frank Questel; Julien Azuar; Claire Paquet; Emmanuel Cognat; Jihed Amami; Mathieu Queneau; Alexandra Dereux; Thomas Barré; Frank Bellivier; Karim Farid; Florence Vorspan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-19       Impact factor: 9.236

3.  Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity.

Authors:  Dardo G Tomasi; Corinde E Wiers; Ehsan Shokri-Kojori; Amna Zehra; Veronica Ramirez; Clara Freeman; Jamie Burns; Christopher Kure Liu; Peter Manza; Sung W Kim; Gene-Jack Wang; Nora D Volkow
Journal:  Int J Neuropsychopharmacol       Date:  2019-09-01       Impact factor: 5.176

4.  Relations between cognitive and motor deficits and regional brain volumes in individuals with alcoholism.

Authors:  Rosemary Fama; Anne-Pascale Le Berre; Stephanie A Sassoon; Natalie M Zahr; Kilian M Pohl; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Brain Struct Funct       Date:  2019-06-03       Impact factor: 3.270

Review 5.  The thalamus in drug addiction: from rodents to humans.

Authors:  Anna S Huang; Jameson A Mitchell; Suzanne N Haber; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

6.  Disruption of cerebellar-cortical functional connectivity predicts balance instability in alcohol use disorder.

Authors:  Eva M Müller-Oehring; Tilman Schulte; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Drug Alcohol Depend       Date:  2022-04-01       Impact factor: 4.852

7.  Attenuated cerebral blood flow in frontolimbic and insular cortices in Alcohol Use Disorder: Relation to working memory.

Authors:  Edith V Sullivan; Qingyu Zhao; Kilian M Pohl; Natalie M Zahr; Adolf Pfefferbaum
Journal:  J Psychiatr Res       Date:  2021-02-02       Impact factor: 4.791

8.  Accelerated aging and motor control deficits are related to regional deformation of central cerebellar white matter in alcohol use disorder.

Authors:  Qingyu Zhao; Adolf Pfefferbaum; Simon Podhajsky; Kilian M Pohl; Edith V Sullivan
Journal:  Addict Biol       Date:  2019-04-01       Impact factor: 4.093

Review 9.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

10.  Jacobian Mapping Reveals Converging Brain Substrates of Disruption and Repair in Response to Ethanol Exposure and Abstinence in 2 Strains of Rats.

Authors:  Qingyu Zhao; Kilian M Pohl; Edith V Sullivan; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol Clin Exp Res       Date:  2020-11-20       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.